160 related articles for article (PubMed ID: 25487734)
1. Electroporation-enhanced delivery of nucleic acid vaccines.
Broderick KE; Humeau LM
Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
[TBL] [Abstract][Full Text] [Related]
2. Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?
Frelin L; Brass A; Ahlén G; Brenndörfer ED; Chen M; Sällberg M
Drug News Perspect; 2010 Dec; 23(10):647-53. PubMed ID: 21180650
[TBL] [Abstract][Full Text] [Related]
3. Electroporation delivery of DNA vaccines: prospects for success.
Sardesai NY; Weiner DB
Curr Opin Immunol; 2011 Jun; 23(3):421-9. PubMed ID: 21530212
[TBL] [Abstract][Full Text] [Related]
4. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
[TBL] [Abstract][Full Text] [Related]
5. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
[TBL] [Abstract][Full Text] [Related]
6. Electroporation-mediated intradermal delivery of DNA vaccines in nonhuman primates.
Adam L; Le Grand R; Martinon F
Methods Mol Biol; 2014; 1121():309-13. PubMed ID: 24510834
[TBL] [Abstract][Full Text] [Related]
7. Electroporation for DNA immunization: clinical application.
van Drunen Littel-van den Hurk S; Hannaman D
Expert Rev Vaccines; 2010 May; 9(5):503-17. PubMed ID: 20450325
[TBL] [Abstract][Full Text] [Related]
8. Electroporation for therapeutic DNA vaccination in patients.
Sällberg M; Frelin L; Ahlén G; Sällberg-Chen M
Med Microbiol Immunol; 2015 Feb; 204(1):131-5. PubMed ID: 25535102
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Delivery of DNA or RNA Vaccines by Electroporation.
Broderick KE; Humeau LM
Methods Mol Biol; 2017; 1499():193-200. PubMed ID: 27987151
[TBL] [Abstract][Full Text] [Related]
10. Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.
Khawaja G; Buronfosse T; Jamard C; Guerret S; Zoulim F; Luxembourg A; Hannaman D; Evans C; Hartmann D; Cova L
Virology; 2012 Mar; 425(1):61-9. PubMed ID: 22284894
[TBL] [Abstract][Full Text] [Related]
11. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
Hum Vaccin Immunother; 2015; 11(3):746-54. PubMed ID: 25839221
[TBL] [Abstract][Full Text] [Related]
12. Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines.
Khan AS; Broderick KE; Sardesai NY
Methods Mol Biol; 2014; 1121():279-89. PubMed ID: 24510832
[TBL] [Abstract][Full Text] [Related]
13. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.
Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY
Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant.
Zhang L; Widera G; Rabussay D
Bioelectrochemistry; 2004 Jun; 63(1-2):369-73. PubMed ID: 15110305
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue: a new target for electroporation-enhanced DNA vaccines.
Fisher PD; Brambila CJ; McCoy JR; Kiosses WB; Mendoza JM; Oh J; Yung BS; Schultheis K; Smith TRF; Broderick KE
Gene Ther; 2017 Dec; 24(12):757-767. PubMed ID: 29106403
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of DNA vaccine potency in rhesus macaques by electroporation.
Otten G; Schaefer M; Doe B; Liu H; Srivastava I; zur Megede J; O'Hagan D; Donnelly J; Widera G; Rabussay D; Lewis MG; Barnett S; Ulmer JB
Vaccine; 2004 Jun; 22(19):2489-93. PubMed ID: 15193413
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccination in skin enhanced by electroporation.
Broderick KE; Khan AS; Sardesai NY
Methods Mol Biol; 2014; 1143():123-30. PubMed ID: 24715285
[TBL] [Abstract][Full Text] [Related]
18. Clinical potential of electroporation for gene therapy and DNA vaccine delivery.
Lambricht L; Lopes A; Kos S; Sersa G; Préat V; Vandermeulen G
Expert Opin Drug Deliv; 2016; 13(2):295-310. PubMed ID: 26578324
[TBL] [Abstract][Full Text] [Related]
19. Electroporation-mediated administration of candidate DNA vaccines against HIV-1.
Vasan S
Methods Mol Biol; 2014; 1121():291-307. PubMed ID: 24510833
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2.
Tian DY; Sun Y; Wai SF; Lee FK; Meng QL; Suen KM; Wang N; Han W; Li S; Li YF; Li D; Ling LJ; Liao YJ; Qiu HJ
Vaccine; 2012 May; 30(24):3587-94. PubMed ID: 22469861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
